{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:18:12Z","timestamp":1773659892214,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymgme.2026.109768","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:45:46Z","timestamp":1770565546000},"page":"109768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of pegvaliase-related skin concerns: best practice recommendations using a modified Delphi approach"],"prefix":"10.1016","volume":"147","author":[{"given":"Alvaro Hermida","family":"Ameijeiras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Vucko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Lah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania Carolina","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Rovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sacharow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2026.109768_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"Van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0015","doi-asserted-by":"crossref","first-page":"107583","DOI":"10.1016\/j.ymgme.2023.107583","article-title":"Phenylketonuria and the brain","volume":"139","author":"Rovelli","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109768_bb0020","doi-asserted-by":"crossref","DOI":"10.4103\/abr.abr_238_23","article-title":"Quality of life in patients with phenylketonuria: a systematic review","volume":"13","author":"Jahangiri","year":"2024","journal-title":"Adv. Biomed. Res."},{"issue":"18","key":"10.1016\/j.ymgme.2026.109768_bb0025","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.3390\/nu16183119","article-title":"Factors affecting adherence to a low phenylalanine diet in patients with phenylketonuria: a systematic review","volume":"16","author":"Yagudin\u0430","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109768_bb0035","author":"BioMarin International Limited"},{"issue":"2","key":"10.1016\/j.ymgme.2026.109768_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2011.10.014","article-title":"START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients","volume":"105","author":"Utz","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109768_bb0045","unstructured":"BioMarin International Limited. PALYNZIQ\u00ae (Pegvaliase-pqpz) Injection, for Subcutaneous Use; Summary of Product Characteristics. Published online 2019. Accessed November 19, 2024. https:\/\/www.ema.europa.eu\/en\/document s\/product-information\/palynziq-epar-product-information_en.pdf."},{"key":"10.1016\/j.ymgme.2026.109768_bb0050","article-title":"Pegvaliase for the treatment of phenylketonuria: final results of a long-term phase 3 clinical trial program","volume":"39","author":"Harding","year":"2024","journal-title":"Mol. Genet Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109768_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2018.06.010","article-title":"Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria","volume":"125","author":"Zori","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109768_bb0060","author":"BioMarin Pharmaceutical Inc"},{"key":"10.1016\/j.ymgme.2026.109768_bb0065","article-title":"Use of pegvaliase in the management of phenylketonuria: case series of early experience in US clinics","volume":"28","author":"Adams","year":"2021","journal-title":"Mol. Genet Metab. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.109768_bb0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2019.05.006","article-title":"Pegvaliase: immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy","volume":"128","author":"Hausmann","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02751-0","article-title":"Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations","volume":"18","author":"Cunningham","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109768_bb0080","article-title":"Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase","volume":"28","author":"Rocha","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.109768_bb0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","article-title":"Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials","volume":"37","author":"Gupta","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2026.109768_bb0090","article-title":"First 1.5 years of pegvaliase clinic: experiences and outcomes","volume":"24","author":"Sacharow","year":"2020","journal-title":"Mol. Genet Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109768_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108122","article-title":"Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: analysis of phase 3 clinical trial data","volume":"141","author":"Rohr","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2026.109768_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.12.005","article-title":"Phenylalanine hydroxylase deficiency treatment and management: a systematic evidence review of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Adams","year":"2023","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107737","article-title":"Best practice recommendations for the management of anxiety during the pegvaliase journey","volume":"141","author":"Bjoraker","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109768_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2020.06.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of the phase 2 dose-finding studies with long-term follow-up","volume":"130","author":"Burton","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2018.03.003","article-title":"Pegvaliase for the treatment of phenylketonuria: a pivotal, double-blind randomized discontinuation phase 3 clinical trial","volume":"124","author":"Harding","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109768_bb0120","unstructured":"Hydery T, Coppenrath VA. A comprehensive review of Pegvaliase, an enzyme substitution therapy for the treatment of phenylketonuria. Drug Target Insights."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109768_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymgme.2021.05.006","article-title":"Palynziq clinic: one year and 43 patients later","volume":"133","author":"Lah","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"9937","key":"10.1016\/j.ymgme.2026.109768_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0858-7","article-title":"Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study","volume":"13","author":"Longo","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109768_bb0140","article-title":"Successful desensitization of Pegvaliase (Palynziq\u00ae) in a patient with phenylketonuria","volume":"23","author":"Patrawala","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.109768_bb0145","article-title":"Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: an Italian model (expert opinion)","volume":"39","author":"Scala","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109768_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108151","article-title":"Pegvaliase therapy for phenylketonuria: real-world case series and clinical insights","volume":"142","author":"Scala","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.109768_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2019.07.018","article-title":"Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria","volume":"128","author":"Zori","year":"2019","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:29:27Z","timestamp":1773656967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922600051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S109671922600051X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109768","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of pegvaliase-related skin concerns: best practice recommendations using a modified Delphi approach","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109768"}}